Association between species diversity and the number of consumers and producers related to L-phenylalanine in HIV-infected and uninfected individuals
| Indicators . | Disease . | HIV stages . | Consumer–producer . | ||||
|---|---|---|---|---|---|---|---|
| Positive . | Negative . | Chronic . | Acute . | Negative . | Consumer . | Producer . | |
| |$\beta$| (95% confidence interval) . | |$\beta$| (95% confidence interval) . | |$\beta$| (95% confidence interval) . | |$\beta$| (95% confidence interval) . | |$\beta$| (95% confidence interval) . | |$\beta$| (95% confidence interval) . | |$\beta$| (95% confidence interval) . | |
| Consumer | 1.14 (1.11–1.18) | 1.18 (1.12–1.23) | 1.13 (1.10–1.67) | 1.14 (0.94–1.34) | 1.22 (1.15–1.28) | 1.16 (1.13–1.19) | — |
| Producer | 2.26 (2.01–2.52) | 2.39 (1.93–2.86) | 2.32 (2.01–2.63) | 2.07 (0.56–3.58 | 2.10 (1.78–2.43) | — | 2.17 (1.95–2.38) |
| Indicators . | Disease . | HIV stages . | Consumer–producer . | ||||
|---|---|---|---|---|---|---|---|
| Positive . | Negative . | Chronic . | Acute . | Negative . | Consumer . | Producer . | |
| |$\beta$| (95% confidence interval) . | |$\beta$| (95% confidence interval) . | |$\beta$| (95% confidence interval) . | |$\beta$| (95% confidence interval) . | |$\beta$| (95% confidence interval) . | |$\beta$| (95% confidence interval) . | |$\beta$| (95% confidence interval) . | |
| Consumer | 1.14 (1.11–1.18) | 1.18 (1.12–1.23) | 1.13 (1.10–1.67) | 1.14 (0.94–1.34) | 1.22 (1.15–1.28) | 1.16 (1.13–1.19) | — |
| Producer | 2.26 (2.01–2.52) | 2.39 (1.93–2.86) | 2.32 (2.01–2.63) | 2.07 (0.56–3.58 | 2.10 (1.78–2.43) | — | 2.17 (1.95–2.38) |
All P-values <.001 (detailed information is found in Table S9).
Association between species diversity and the number of consumers and producers related to L-phenylalanine in HIV-infected and uninfected individuals
| Indicators . | Disease . | HIV stages . | Consumer–producer . | ||||
|---|---|---|---|---|---|---|---|
| Positive . | Negative . | Chronic . | Acute . | Negative . | Consumer . | Producer . | |
| |$\beta$| (95% confidence interval) . | |$\beta$| (95% confidence interval) . | |$\beta$| (95% confidence interval) . | |$\beta$| (95% confidence interval) . | |$\beta$| (95% confidence interval) . | |$\beta$| (95% confidence interval) . | |$\beta$| (95% confidence interval) . | |
| Consumer | 1.14 (1.11–1.18) | 1.18 (1.12–1.23) | 1.13 (1.10–1.67) | 1.14 (0.94–1.34) | 1.22 (1.15–1.28) | 1.16 (1.13–1.19) | — |
| Producer | 2.26 (2.01–2.52) | 2.39 (1.93–2.86) | 2.32 (2.01–2.63) | 2.07 (0.56–3.58 | 2.10 (1.78–2.43) | — | 2.17 (1.95–2.38) |
| Indicators . | Disease . | HIV stages . | Consumer–producer . | ||||
|---|---|---|---|---|---|---|---|
| Positive . | Negative . | Chronic . | Acute . | Negative . | Consumer . | Producer . | |
| |$\beta$| (95% confidence interval) . | |$\beta$| (95% confidence interval) . | |$\beta$| (95% confidence interval) . | |$\beta$| (95% confidence interval) . | |$\beta$| (95% confidence interval) . | |$\beta$| (95% confidence interval) . | |$\beta$| (95% confidence interval) . | |
| Consumer | 1.14 (1.11–1.18) | 1.18 (1.12–1.23) | 1.13 (1.10–1.67) | 1.14 (0.94–1.34) | 1.22 (1.15–1.28) | 1.16 (1.13–1.19) | — |
| Producer | 2.26 (2.01–2.52) | 2.39 (1.93–2.86) | 2.32 (2.01–2.63) | 2.07 (0.56–3.58 | 2.10 (1.78–2.43) | — | 2.17 (1.95–2.38) |
All P-values <.001 (detailed information is found in Table S9).
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
